N,N-DIBENZYL-TADDOL-PHOSPHORAMIDITE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 4qcqzXJW9MD |
|---|---|
| InChI | InChI=1S/C45H42NO4P/c1-43(2)47-41-42(48-43)45(39-29-17-7-18-30-39,40-31-19-8-20-32-40)50-51(46(33-35-21-9-3-10-22-35)34-36-23-11-4-12-24-36)49-44(41,37-25-13-5-14-26-37)38-27-15-6-16-28-38/h3-32,41-42H,33-34H2,1-2H3/t41-,42-/m1/s1 |
| InChIKey | NZCPWTVFKFPAGS-NCRNUEESSA-N |
| Mol Weight | 691.8 g/mol |
| Molecular Formula | C45H42NO4P |
| Exact Mass | 691.285146 g/mol |
| Enantiomer InChIKey | NZCPWTVFKFPAGS-COCZKOEFSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
N-(MORPHOLINO)-TADDOL-PHOSPHORAMIDITE
N,N-METHYL,PHENYL-TADDOL-PHOSPHORAMIDITE
(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]-DIOXOLO-[4,5-E]-[1,3,2]-DIOXAPHOSPHEPIN-6-YL)-(1-PHENYL-ETHYL)-AMINE
O-(2'-NAPHTHYL)-TADDOL-PHOSPHITE
(3aR,8aR)-2,2-dimethyl-4,4,6,8,8-pentakis-phenyl-3a,8a-dihydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin
9,9-Dimethyl-4-(4'-methylphenyl)-2,2,6,6-tetraphenyl-3,5,8,10-tetraoxa-4-phosphabicyclo[5.3.0]decane
(R,R)-4-(N-Benzylideneiminodiphenylmethyl)-2,2-dimethyl-3-(diphenylhydroxymethyl)-1,3-dioxolane
1,4-Anhydro-1-(2,4-diamino-5-pyrimidinyl)-2,3-O-(1-methylethylidene)-5-O-tritylpentitol
2-{ Diphenyl [(trimethylsilyl)oxy] methyl }-2-ethoxy-4,4-diphenyl-4-[(trimethylsilyl)oxy] butane nitrile
(4-R,5-R,1'-S,2'-S)-2-[2-[3-TERT.-BUTYL-(DIPHENYL)-SILOXYPROPYL]-CYCLOPROPYL]-4,5-BIS-[METHOXY-(DIPHENYL)-METHYL]-1,3,2-DIOXABOROLANE
| Title | Journal or Book | Year |
|---|---|---|
| TADDOL-Derived Phosphites and Phosphoramidites for Efficient Rhodium-Catalyzed Asymmetric Hydroboration | Organic Letters | 2006 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.